Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

2018 Dengue Vaccines Drug Analysis: An Emerging Flaviviral Infection Transmitted Mainly by Aedes Aegypti and Aedes Albopictus Mosquitoes -

Research and Markets
Posted on: 15 Feb 18

The "Drug Analysis: Dengue Vaccines" drug pipelines has been added to's offering.

Dengue fever is an emerging flaviviral infection transmitted mainly by Aedes aegypti and Aedes albopictus mosquitoes. The dengue burden has expanded rapidly over the last few decades, and the disease is now endemic in many Latin American and Asia-Pacific countries, with 75% of the at-risk population residing in the latter region. Dengue usually manifests as a severe flu-like illness, with symptoms including headache, retro-orbital pain, muscle pain, and vomiting, but 1-3% of infections will manifest as dengue hemorrhagic fever, characterized by plasma leakage, severe bleeding, and respiratory distress.

Market Snapshot

  • Safety concerns in seronegative patients will severely lower Dengvaxia's uptake for the foreseeable future.
  • TAK-003 is expected to replace Dengvaxia as the preferred vaccine for routine immunizations in lucrative Asia-Pacific markets.

Key Topics Covered:

Marketed Vaccines: Dengue Fever

  • Executive Summary
  • Product Profile: Dengvaxia

Pipeline Vaccines: Dengue Fever

  • Executive Summary
  • Clinical Pipeline Overview
  • Primary Research Methodology
  • Product Profile (Late Stage): Dpiv
  • Product Profile (Late Stage): Dengue Dna Vaccine
  • Product Profile (Late Stage): Tak-003
  • Product Profile (Late Stage): Tetravax-Dv
  • Product Profile (Late Stage): V180

For more information about this drug pipelines report visit

View source version on

Business Wire

Last updated on: 15/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.